Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_assertion type Assertion NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_head.
- NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_assertion description "[AMG 925 is a dual FLT3/CDK4 inhibitor with the potential to overcome FLT3 inhibitor resistance in acute myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_provenance.
- NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_assertion evidence source_evidence_literature NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_provenance.
- NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_assertion SIO_000772 25487917 NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_provenance.
- NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_assertion wasDerivedFrom befree-2016 NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_provenance.
- NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_assertion wasGeneratedBy ECO_0000203 NP1246258.RAYkzab1IUuuWNt60C12XMr9dBVT3r2YKa8kTURY2BQv0130_provenance.